Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
227.86
-0.04 (-0.02%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Quest Diagnostics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 11,560 | 11,035 | 9,872 | 9,252 | 9,883 | 10,788 | |
Revenue Growth (YoY) | 9.87% | 11.78% | 6.70% | -6.39% | -8.39% | 14.32% |
Cost of Revenue | 7,732 | 7,370 | 6,628 | 6,199 | 6,450 | 6,579 |
Gross Profit | 3,828 | 3,665 | 3,244 | 3,053 | 3,433 | 4,209 |
Selling, General & Admin | 2,038 | 1,967 | 1,770 | 1,642 | 1,874 | 1,727 |
Depreciation & Amortization Expenses | 151 | 154 | 127 | 108 | 120 | 103 |
Other Operating Expenses | 9 | -12 | 1 | 41 | 11 | -2 |
Total Operating Expenses | 2,198 | 2,109 | 1,898 | 1,791 | 2,005 | 1,828 |
Operating Income | 1,630 | 1,556 | 1,346 | 1,262 | 1,428 | 2,381 |
Interest Income | 29 | 42 | 19 | 26 | 44 | 78 |
Interest Expense | -256 | -264 | -201 | -152 | -138 | -151 |
Other Non-Operating Income (Expense) | 30 | 26 | 30 | 20 | -55 | 369 |
Total Non-Operating Income (Expense) | -197 | -196 | -152 | -106 | -149 | 296 |
Pretax Income | 1,433 | 1,360 | 1,194 | 1,156 | 1,279 | 2,677 |
Provision for Income Taxes | 320 | 314 | 273 | 248 | 264 | 597 |
Net Income | 1,113 | 1,046 | 921 | 908 | 1,015 | 2,080 |
Minority Interest in Earnings | 51 | 54 | 50 | 54 | 69 | 85 |
Net Income to Common | 1,062 | 992 | 871 | 854 | 946 | 1,995 |
Net Income Growth | 11.79% | 13.89% | 1.99% | -9.72% | -52.58% | 39.41% |
Shares Outstanding (Basic) | 111 | 111 | 111 | 112 | 116 | 125 |
Shares Outstanding (Diluted) | 112 | 113 | 113 | 113 | 118 | 128 |
Shares Change (YoY) | -0.66% | - | - | -4.24% | -7.81% | -5.88% |
EPS (Basic) | 9.54 | 8.87 | 7.78 | 7.59 | 8.10 | 15.85 |
EPS (Diluted) | 9.42 | 8.75 | 7.69 | 7.49 | 7.97 | 15.55 |
EPS Growth | 12.81% | 13.78% | 2.67% | -6.02% | -48.75% | 48.52% |
Free Cash Flow | 1,349 | 1,359 | 909 | 864 | 1,314 | 1,830 |
Free Cash Flow Growth | 10.21% | 49.50% | 5.21% | -34.25% | -28.20% | 15.31% |
Free Cash Flow Per Share | 12.02 | 12.03 | 8.04 | 7.65 | 11.14 | 14.30 |
Dividends Per Share | 3.320 | 3.200 | 3.000 | 2.840 | 2.640 | 2.480 |
Dividend Growth | 7.10% | 6.67% | 5.63% | 7.58% | 6.45% | 10.71% |
Gross Margin | 33.11% | 33.21% | 32.86% | 33.00% | 34.74% | 39.02% |
Operating Margin | 14.10% | 14.10% | 13.63% | 13.64% | 14.45% | 22.07% |
Profit Margin | 9.63% | 9.48% | 9.33% | 9.81% | 10.27% | 19.28% |
FCF Margin | 11.67% | 12.32% | 9.21% | 9.34% | 13.30% | 16.96% |
EBITDA | 2,357 | 2,126 | 1,839 | 1,701 | 1,865 | 2,789 |
EBITDA Margin | 20.39% | 19.27% | 18.63% | 18.39% | 18.87% | 25.85% |
EBIT | 1,630 | 1,556 | 1,346 | 1,262 | 1,428 | 2,381 |
EBIT Margin | 14.10% | 14.10% | 13.63% | 13.64% | 14.45% | 22.07% |
Effective Tax Rate | 22.33% | 23.09% | 22.86% | 21.45% | 20.64% | 22.30% |